Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
It was so interesting to see that after it was ranked absolutely last on the 6 month review (besides US Mobility, which they sold!)

From 6-month Review

Company: CNS
Prospects: C-
Price: B-

CNS (Nasdaq: CNXS)
Although CNS has other product lines, the company lives and dies with the results in its Breathe Rite strips. Management has proved incapable of branching out with much success, and each attempt to develop (or buy) new products takes capital. Its FiberChoice line seems to be gaining traction. But at an estimated $21 million in fiscal 2006 revenues, it's not the winner CNS needs. But CNS bought back $14 million of shares, to go along with a 1.2% dividend, so I shouldn't overargue that cash is being squandered. This is a fine company with a management that needs to figure out the best use of shareholder capital. Buy below $21.
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.